SUSY Study (SUture StudY) Comparing Scarring With Polypropylene vs Polyglactin 910 Sutures
Launched by IMPERIAL COLLEGE HEALTHCARE NHS TRUST · Jan 21, 2021
Trial Information
Current as of August 11, 2025
Suspended
Keywords
ClinConnect Summary
Purpose and design This study will be the first of its kind to address the difference in inflammatory reaction between these two sutures in entropion repair surgery. Both sutures are widely used in the NHS in eyelid surgery already. The study design has involved peer review from eminent doctors and two statisticians. The questionnaire development involved patients.
Recruitment Patients will be recruited from the oculoplastic clinics at the Western Eye Hospital and Royal Bournemouth Hospital where they will be approached by the principal investigator and colleagues who are also members of t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (aged 18 years or over)
- • Diagnosis of involutional entropion with sufficient lid laxity for a wedge excision
- • Ability to provide informed consent
- Exclusion Criteria:
- • Aged under 18 years
- • Prior lower eyelid surgery
- • Predisposing conditions and treatments known to interfere with scarring and healing
- • Concurrent steroid treatment
- • Addison's disease
- • Poorly controlled diabetes
- • History of keloid scarring
- • History or current cicatrizing disease
- • Warfarin
- • Unable to provide informed consent No one will be unfairly excluded/included in the research
About Imperial College Healthcare Nhs Trust
Imperial College Healthcare NHS Trust is a leading healthcare provider in London, renowned for its commitment to delivering high-quality patient care and advancing medical research. As an integral part of the NHS, the Trust encompasses a range of specialized services and facilities, including multiple hospitals and outpatient centers, where it fosters a collaborative environment for clinical trials. With a focus on innovation and excellence, Imperial College Healthcare NHS Trust supports a diverse portfolio of clinical research initiatives aimed at translating scientific discoveries into effective treatments and improving health outcomes for patients. Its partnership with Imperial College London enhances its capabilities in cutting-edge research, making it a pivotal institution in the landscape of healthcare and clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials